• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首例土耳其甲状旁腺功能减退、耳聋和肾发育不全(HDR)综合征病例。

The First Turkish Case of Hypoparathyroidism, Deafness and Renal Dysplasia (HDR) Syndrome.

作者信息

Döneray Hakan, Usui Takeshi, Kaya Avni, Dönmez Ayşe Sena

机构信息

Atatürk University Faculty of Medicine, Department of Pediatric Endocrinology, Erzurum, Turkey Phone: +90 535 944 43 07 E-mail:

出版信息

J Clin Res Pediatr Endocrinol. 2015 Jun;7(2):140-3. doi: 10.4274/jcrpe.1874.

DOI:10.4274/jcrpe.1874
PMID:26316437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4563186/
Abstract

Hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome is an autosomal dominant genetic disorder characterized by hypoparathyroidism, sensorineural deafness and renal dysplasia. We herein present the first Turkish patient with HDR syndrome, who has a p.R367X mutation. This report indicates that p.R367X is not a mutation specific for the Far Eastern populations and also that urological findings in infants with hypoparathyroidism should be carefully examined because clinical findings relating to the p.R367X mutation may show a variable age of onset.

摘要

甲状旁腺功能减退、耳聋和肾发育异常(HDR)综合征是一种常染色体显性遗传病,其特征为甲状旁腺功能减退、感音神经性耳聋和肾发育异常。我们在此报告首例患有HDR综合征的土耳其患者,该患者存在p.R367X突变。本报告表明,p.R367X并非远东人群特有的突变,同时还表明,对于甲状旁腺功能减退的婴儿,应仔细检查其泌尿系统表现,因为与p.R367X突变相关的临床症状可能具有不同的发病年龄。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/155e/4563186/26c914884d18/JCRPE-7-140-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/155e/4563186/26c914884d18/JCRPE-7-140-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/155e/4563186/26c914884d18/JCRPE-7-140-g2.jpg

相似文献

1
The First Turkish Case of Hypoparathyroidism, Deafness and Renal Dysplasia (HDR) Syndrome.首例土耳其甲状旁腺功能减退、耳聋和肾发育不全(HDR)综合征病例。
J Clin Res Pediatr Endocrinol. 2015 Jun;7(2):140-3. doi: 10.4274/jcrpe.1874.
2
Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction.一名患有甲状旁腺功能减退、感音神经性耳聋和肾发育不良(HDR)综合征并伴有脑梗死的患者的新生儿诊断。
J Pediatr Endocrinol Metab. 2014 Sep;27(9-10):961-5. doi: 10.1515/jpem-2014-0004.
3
Unusual Proliferative Glomerulonephritis in a Patient Diagnosed to Have Hypoparathyroidism, Sensorineural Deafness, and Renal Dysplasia (HDR) Syndrome with a Novel Mutation in the GATA3 Gene.一名被诊断患有甲状旁腺功能减退、感音神经性耳聋和肾发育不良(HDR)综合征且GATA3基因存在新突变的患者出现的不寻常增殖性肾小球肾炎。
Intern Med. 2017;56(11):1393-1397. doi: 10.2169/internalmedicine.56.7930. Epub 2017 Jun 1.
4
Renal phenotypic variability in HDR syndrome: glomerular nephropathy as a novel finding.HDR 综合征的肾脏表型变异性:肾小球肾病作为一种新的发现。
Eur J Pediatr. 2013 Jan;172(1):107-10. doi: 10.1007/s00431-012-1845-y. Epub 2012 Oct 5.
5
Familial congenital choanal atresia with GATA3 associated hypoparathyroidism-deafness-renal dysplasia syndrome unidentified on auditory brainstem response.家族性先天性后鼻孔闭锁合并GATA3相关的甲状旁腺功能减退-耳聋-肾发育不良综合征,听觉脑干反应未明确诊断。
Auris Nasus Larynx. 2019 Oct;46(5):808-812. doi: 10.1016/j.anl.2018.10.005. Epub 2018 Nov 2.
6
The first Korean case of HDR syndrome confirmed by clinical and molecular investigation.首例经临床和分子学调查确诊的韩国遗传性齿釉质发育不全综合征病例。
Yonsei Med J. 2015 Jan;56(1):300-3. doi: 10.3349/ymj.2015.56.1.300.
7
A novel GATA3 nonsense mutation in a newly diagnosed adult patient of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.一个新诊断的甲状旁腺功能减退、耳聋和肾发育不良(HDR)综合征的成年患者中发现的 GATA3 无义突变。
Endocr Pract. 2013 Jan-Feb;19(1):e17-20. doi: 10.4158/EP12186.CR.
8
A Novel De Novo GATA Binding Protein 3 Mutation in a Turkish Boy with Hypoparathyroidism, Deafness, and Renal Dysplasia Syndrome.一名患有甲状旁腺功能减退、耳聋和肾发育不良综合征的土耳其男孩中发现一种新的GATA结合蛋白3从头突变。
J Clin Res Pediatr Endocrinol. 2015 Dec;7(4):344-8. doi: 10.4274/jcrpe.2249.
9
Clinical Auditory Phenotypes Associated with Gene Mutations in Familial Hypoparathyroidism-deafness-renal Dysplasia Syndrome.与家族性甲状旁腺功能减退-耳聋-肾发育不良综合征基因突变相关的临床听觉表型
Chin Med J (Engl). 2017 Mar 20;130(6):703-709. doi: 10.4103/0366-6999.201600.
10
A novel loss-of-function mutation of GATA3 (p.R299Q) in a Japanese family with Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) syndrome.一个患有甲状旁腺功能减退、耳聋和肾发育不良(HDR)综合征的日本家庭中,GATA3基因出现一种新的功能丧失突变(p.R299Q)。
BMC Endocr Disord. 2015 Oct 30;15:66. doi: 10.1186/s12902-015-0065-7.

引用本文的文献

1
A novel frameshift variant of GATA3 (p.Ala17ProfsTer178) responsible for HDR syndrome in a Japanese family.一个新的 GATA3 移码变异(p.Ala17ProfsTer178)导致一个日本家族的 HDR 综合征。
Endocr J. 2024 Nov 1;71(11):1077-1086. doi: 10.1507/endocrj.EJ24-0147. Epub 2024 Aug 27.
2
Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life.全外显子组测序对出生后一千天内诊断的CAKUT患者的诊断率及益处
Kidney Int Rep. 2023 Aug 14;8(11):2439-2457. doi: 10.1016/j.ekir.2023.08.008. eCollection 2023 Nov.
3
A gene mutation that causes incorrect splicing and HDR syndrome: a case study and literature review.

本文引用的文献

1
Germinal mosaicism of GATA3 in a family with HDR syndrome.一个患有HDR综合征的家族中GATA3的生殖系嵌合现象。
Am J Med Genet A. 2009 Feb 15;149A(4):776-8. doi: 10.1002/ajmg.a.32706.
2
HDR syndrome: a novel "de novo" mutation in GATA3 gene.HDR综合征:GATA3基因中的一种新型“从头”突变。
Am J Med Genet A. 2009 Feb 15;149A(4):770-5. doi: 10.1002/ajmg.a.32689.
3
Novel mutation in the gene encoding the GATA3 transcription factor in a Spanish familial case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with female genital tract malformations.
一种导致异常剪接和HDR综合征的基因突变:病例研究及文献综述
Front Genet. 2023 Aug 25;14:1254556. doi: 10.3389/fgene.2023.1254556. eCollection 2023.
4
A rare case of deafness and renal abnormalities in HDR syndrome caused by a de novo mutation in the GATA3 gene.一例由GATA3基因新发突变引起的HDR综合征伴耳聋和肾脏异常的罕见病例。
Genet Mol Biol. 2018 Oct-Dec;41(4):794-798. doi: 10.1590/1678-4685-GMB-2017-0194. Epub 2018 Nov 14.
5
Endocrine Glands and Hearing: Auditory Manifestations of Various Endocrine and Metabolic Conditions.内分泌腺与听力:各种内分泌和代谢疾病的听觉表现
Indian J Endocrinol Metab. 2017 May-Jun;21(3):464-469. doi: 10.4103/ijem.IJEM_10_17.
6
A Novel De Novo GATA Binding Protein 3 Mutation in a Turkish Boy with Hypoparathyroidism, Deafness, and Renal Dysplasia Syndrome.一名患有甲状旁腺功能减退、耳聋和肾发育不良综合征的土耳其男孩中发现一种新的GATA结合蛋白3从头突变。
J Clin Res Pediatr Endocrinol. 2015 Dec;7(4):344-8. doi: 10.4274/jcrpe.2249.
西班牙一例伴有女性生殖道畸形的家族性甲状旁腺功能减退、耳聋和肾发育不良(HDR)综合征患者中,编码GATA3转录因子的基因发生新型突变。
Am J Med Genet A. 2007 Apr 1;143A(7):757-62. doi: 10.1002/ajmg.a.31617.
4
Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor.导致甲状旁腺功能减退 - 耳聋 - 肾脏(HDR)发育异常综合征的GATA3突变的功能特征:深入了解GATA3转录因子的DNA结合机制
Hum Mol Genet. 2007 Feb 1;16(3):265-75. doi: 10.1093/hmg/ddl454. Epub 2007 Jan 8.
5
Functional analysis of a novel GATA3 mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome.一个患有甲状旁腺功能减退、耳聋和肾发育不良综合征的家族中一种新型GATA3突变的功能分析。
J Clin Endocrinol Metab. 2005 Apr;90(4):2445-50. doi: 10.1210/jc.2004-1969. Epub 2005 Feb 10.
6
Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.甲状旁腺功能减退、耳聋和肾发育不良(HDR)综合征中GATA3突变的特征分析。
J Biol Chem. 2004 May 21;279(21):22624-34. doi: 10.1074/jbc.M401797200. Epub 2004 Feb 24.
7
GATA3 abnormalities and the phenotypic spectrum of HDR syndrome.GATA3异常与HDR综合征的表型谱
J Med Genet. 2001 Jun;38(6):374-80. doi: 10.1136/jmg.38.6.374.
8
GATA3 haplo-insufficiency causes human HDR syndrome.GATA3单倍体不足导致人类高免疫球蛋白D和周期性发热综合征。
Nature. 2000 Jul 27;406(6794):419-22. doi: 10.1038/35019088.
9
Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia.
N Engl J Med. 1992 Oct 8;327(15):1069-74. doi: 10.1056/NEJM199210083271506.
10
Expression of GATA-3 during lymphocyte differentiation and mouse embryogenesis.GATA-3在淋巴细胞分化和小鼠胚胎发育过程中的表达。
Dev Immunol. 1992;3(1):1-11. doi: 10.1155/1992/27903.